Fundraising Fox

Perfuse Therapeutics

San Francisco, US · Founded 2018 · Delaware corporation · 6 known investors

in /perfusetherapeutics

Founders & leadership

CK
Chau KhuongDirector
SG
Sevgi GurkanExecutive Officer, Director, Promoter
CS
Christy ShafferDirector

Investors · 6

Access BiotechnologyNew York City
Catalio Capital Management, LPNew York
Hatteras Venture PartnersResearch Triangle · $500K – $4M
LAVHong Kong · $5M – $15M
Lilly Asia VenturesHong Kongvia Hongbo Lu · board
OrbiMedNew York · $1M – $75Mvia Chau Khuong · board

Reported raises · per SEC filings

Form D private placements
▶$9MraisedJul 2020 · 8 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Hongbo LuDirector
  • Christy ShafferDirector
  • Chau KhuongDirector
  • Sevgi GurkanExecutive Officer, Director, Promoter
  • Dan BeckerDirector
  • Jerry CagleDirector
Offering amount
$39M
Amount sold
$9M
First sale
Jul 2020
Incorporated
Corporation, Delaware, 2018
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$2MraisedApr 2019 · 6 investors · Other Technology
Rule 506(b)
Officers, directors & promoters on the filing
  • Christy ShafferDirector
  • Chau KhuongDirector
  • Sevgi GurkanExecutive Officer, Director, Promoter
Offering amount
$4M
Amount sold
$2M
First sale
Mar 2019
Incorporated
Corporation, Delaware, 2018
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.